Tranexamic Acid Tablets Manufacturer in India | Antifibrinolytic Exporter

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Tranexamic Acid Tablets are antifibrinolytic medications used for the treatment and prevention of excessive bleeding in various medical conditions. The medicine works by preventing the breakdown of fibrin clots through inhibition of plasminogen activation, thereby helping maintain stable blood clots and reducing bleeding. Genliva Wellness LLP is a trusted Tranexamic Acid Tablet Manufacturer in India offering high-quality hospital and specialty pharmaceutical formulations for domestic and international markets.

Tranexamic Acid is commonly prescribed for heavy menstrual bleeding (menorrhagia), surgical bleeding prevention, and other conditions associated with abnormal fibrinolysis. It helps reduce blood loss and supports stable hemostasis in both acute and chronic bleeding conditions. As a reliable Tranexamic Acid Tablet Exporter from India, Genliva Wellness LLP supplies quality-assured pharmaceutical products to healthcare providers and distributors worldwide.

Tranexamic Acid Tablets are widely used in gynecology, surgery, and general medicine as an effective oral antifibrinolytic therapy.

Tranexamic Acid Tablets are formulated to reduce excessive bleeding through antifibrinolytic action.

Contains Tranexamic Acid as the active ingredient
Antifibrinolytic therapeutic agent
Inhibits plasmin-mediated fibrin breakdown
Stabilizes blood clots
Reduces excessive menstrual and surgical bleeding
Supports hemostatic balance

Tranexamic Acid Tablets are used in the treatment and management of bleeding disorders.

Heavy menstrual bleeding (menorrhagia)
Surgical bleeding prevention
Postoperative bleeding control
Trauma-related mild bleeding
Epistaxis (nosebleeds)
General bleeding disorders

Tranexamic Acid Tablets provide effective control of abnormal bleeding conditions.

Helps reduce menstrual blood loss
Stabilizes clot formation
Supports management of surgical bleeding
Reduces risk of excessive hemorrhage
Provides oral antifibrinolytic therapy option
Improves hemostatic control in various conditions